AbbVie Inc (ABBV)

ABBV (NYSE:Drugs) EQUITY
$62.71
pos +0.00
+0.00%
Today's Range: 61.83 - 63.22 | ABBV Avg Daily Volume: 8,786,800
Last Update: 07/01/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 5.86%
Open: $0.00
Previous Close: $61.91
52 Week Range: $45.45 - $71.60
Oustanding Shares: 1,617,358,607
Market Cap: 100,130,671,359
6-Month Chart
TheStreet Ratings Grade for ABBV
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 9
Moderate Buy 0 1 1 1
Hold 6 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
Mean Rec. 2.14 1.81 1.81 1.50
Latest Dividend: 0.57
Latest Dividend Yield: 3.68%
Dividend Ex-Date: 07/13/16
Price Earnings Ratio: 18.59
Price Earnings Comparisons:
ABBV Sector Avg. S&P 500
18.59 18.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.21% -8.47% 50.71%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.50 0.20 0.07
Net Income 190.00 0.00 -0.01
EPS 185.20 -0.10 -0.02
Earnings for ABBV:
EBITDA 8.37B
Revenue 22.86B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.20 $1.18 $4.77 $5.69
Number of Analysts 8 6 10 10
High Estimate $1.21 $1.24 $4.85 $5.96
Low Estimate $1.19 $1.14 $4.68 $5.35
Prior Year $1.08 $1.13 $4.29 $4.77
Growth Rate (Year over Year) 11.11% 4.72% 11.24% 19.17%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

David Katz

 | Jun 29, 2016 | 8:00 AM EDT

These names are now oversold and are sitting at attractive prices.

By

Anders Keitz

 | Jun 15, 2016 | 1:30 PM EDT

Analysts cut valuation estimates after a disappointing drug study. 

By

David Katz

 | Jun 15, 2016 | 8:00 AM EDT

With the recent pullback in the stock price, AbbVie is an attractive buy.  

By

Real Money

 | Jun 13, 2016 | 4:33 PM EDT

Social media chatter on Wall Street ranged from new forms of so-called 'thematic ETFs' to spiking volatility.

bearishAbbvie downgraded at BMO

Jun 10, 2016 | 7:53 AM EDT

ABBV was downgraded from Outperform to Market Perform, BMO Capital said. $66 price target. Uncertainty is increasing around major growth drivers. 

By

Bruce Kamich

 | Jun 6, 2016 | 1:58 PM EDT

Further near-term weakness to $60 looks like a good spot to go long. Use an appropriate risk level.

By

Jim Cramer

 | Jun 3, 2016 | 5:37 AM EDT

This is because they would buy more of the winning stocks lower.

By

Bret Jensen

 | May 31, 2016 | 10:00 AM EDT

The uptick in the small- and mid-cap space bodes well for future capital appreciation.

By

Bret Jensen

 | May 27, 2016 | 2:52 PM EDT
The market is having a quiet day in front of the long holiday weekend. However, biotech is concluding another strong week, which makes two in a row. I'm noticing some small biotechs on the move today.
By

Bret Jensen

 | May 24, 2016 | 11:00 AM EDT

Keep cash on hand and be ready for oportunities as they arise.

I've been on the wrong side of this one in the near-term.  What a unicorn.  Guess Cramer...
Markets trying to make it four days up in a row and erase all of the Brexit losses. Would...
HOG is up about $5.75 per share today on a sharp spike in daily trading volume. As of noon...
Ruby Tuesday up 3% presumably due to plans to open Tesla Supercharger Stations at some loc...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.